OTCMKTS:MITI Mitesco (MITI) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free MITI Stock Alerts $0.45 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.27▼$0.4550-Day Range$0.22▼$0.6452-Week Range$0.02▼$1.48Volume369 shsAverage Volume1,249 shsMarket Capitalization$2.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsStock AnalysisChartEarningsFinancialsHeadlinesSEC Filings Get Mitesco alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Mitesco Stock (OTCMKTS:MITI)Mitesco, Inc. operates medical clinics under The Good Clinic name. The company offers healthcare technology and services. It also provides preventative and wellness care, primary and behavioral care service, nutrition coaching, telehealth care, and population health related services. In addition, the company sells books, vitamins, supplements, and essential oil related products. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco, Inc. is based in Deephaven, Minnesota.Read More MITI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MITI Stock News HeadlinesApril 26, 2024 | globenewswire.comMitesco Expands Advisory Board With Senior Technology, Infrastructure ExecsApril 17, 2024 | finance.yahoo.comMitesco Announces Investor Call, Begins New Data Center and Infrastructure InitiativeApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 17, 2024 | globenewswire.comMitesco Announces Investor Call, Begins New Data Center and Infrastructure InitiativeMarch 19, 2024 | globenewswire.comMitesco Announces Advisory Board AppointmentsMarch 7, 2024 | globenewswire.comMitesco Continues Key Initiatives, UpdatesFebruary 15, 2024 | finanznachrichten.deMitesco, Inc.: Mitesco Provides Shareholder UpdateFebruary 15, 2024 | finance.yahoo.comMitesco Provides Shareholder UpdateApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 15, 2024 | globenewswire.comMitesco Provides Shareholder UpdateJanuary 31, 2024 | msn.comMitesco Settles Wrongful Termination Lawsuit, Closes ClinicsSeptember 4, 2023 | msn.comIPO Roundup: Arm Holdings, Prospect Energy Holdings and moreAugust 30, 2023 | msn.comClinic operator Mitesco withdraws plans for offering, uplistingJuly 18, 2023 | finanznachrichten.deMitesco, Inc.: Mitesco Appoints Mr. Allen Plunk to its Board of DirectorsJuly 18, 2023 | finance.yahoo.comMitesco Appoints Mr. Allen Plunk to its Board of DirectorsJune 6, 2023 | seekingalpha.comMitesco announces management changesJune 6, 2023 | msn.comMitesco announce management changesJune 6, 2023 | finance.yahoo.comMitesco Inc. Appoints Sheila Schweitzer Chairman of the Board and COODecember 19, 2022 | finance.yahoo.comMitesco, Inc. Continues on Uplist Path, Evaluates Potential Joint Venture and Alternative Funding Opportunities for The Good Clinic BusinessOctober 12, 2022 | marketscreener.comMITESCO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K) - Marketscreener.comOctober 12, 2022 | streetinsider.comForm 8-K Mitesco, Inc. For: Oct 05 - StreetInsider.comSeptember 11, 2022 | finance.yahoo.comMitesco, Inc. (MITI)September 8, 2022 | streetinsider.comThe Good Clinic Expands Services with Pharmacogenetic Testing by Xact Laboratories - StreetInsider.comAugust 25, 2022 | streetinsider.comForm 8-K Mitesco, Inc. For: Aug 18 - StreetInsider.comAugust 17, 2022 | businesswire.comThe Good Clinic Partners with athenahealth to Empower Providers and Patients to Engage in Personalized, Relationship-Driven Healthcare at Scale - Business WireAugust 16, 2022 | marketscreener.comMITESCO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.comAugust 12, 2022 | streetinsider.comForm 10-Q Mitesco, Inc. For: Jun 30 - StreetInsider.comSee More Headlines Receive MITI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mitesco and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Health services Sub-IndustryN/A Current SymbolOTCMKTS:MITI CUSIPN/A CIK802257 Webtruenatureholding.com Phone(844) 383-8689Fax866-331-2441Employees27Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,330,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-8,798.60% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$690,000.00 Price / Sales3.68 Cash FlowN/A Price / Cash FlowN/A Book Value($2.54) per share Price / Book-0.18Miscellaneous Outstanding Shares5,640,000Free Float5,359,000Market Cap$2.54 million OptionableNot Optionable Beta2.18 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Michael Craig Howe (Age 71)Chief Executive Officer of The Good Clinic Mr. Mack Leath (Age 67)Chairman of the Board, CEO & CFO Mr. Louis George Deluca Jr. (Age 65)Business Operations Consultant Comp: $63.5kMr. Ronald Riewold (Age 75)Strategic Advisor Comp: $12.5kMr. Bradley D. Case CMPEPresident of The Good ClinicMr. John Mitchell (Age 54)Secretary, Treasurer & Director More ExecutivesKey CompetitorsPear TherapeuticsNASDAQ:PEARUnion DentalOTCMKTS:UDHIQuoin PharmaceuticalsNASDAQ:QNRXSonoma PharmaceuticalsNASDAQ:SNOAAltamira TherapeuticsNASDAQ:CYTOView All Competitors MITI Stock Analysis - Frequently Asked Questions How have MITI shares performed in 2024? Mitesco's stock was trading at $0.03 at the start of the year. Since then, MITI stock has increased by 1,400.0% and is now trading at $0.45. View the best growth stocks for 2024 here. How were Mitesco's earnings last quarter? Mitesco, Inc. (OTCMKTS:MITI) announced its earnings results on Tuesday, February, 13th. The company reported ($0.39) earnings per share for the quarter. How do I buy shares of Mitesco? Shares of MITI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MITI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mitesco, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.